欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/6273/001
药品名称Fingolimod-ratiopharm 0,25 mg Hartkapseln
活性成分
    • fingolimod hydrochloride 0.25 mg
剂型Capsule, hard
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Fingolimod-ratiopharm 0,25 mg Hartkapseln
互认成员国 - 产品名称
    • Belgium (BE)
      Fingolimod Teva 0,25 mg harde capsules
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
      Fingolimod Teva
    • Poland (PL)
      Fingolimod Teva
    • Slovenia (SI)
    • Croatia (HR)
      Fingolimod Teva 0,25 mg tvrde kapsule
许可日期2020/09/03
最近更新日期2024/04/02
药物ATC编码
    • L04AA27 fingolimod
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase